Position in GILD
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$343,139
-$113,855 QoQ
Shares Held
2,716
-17.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,582
of 2,266 holders
Holding Since
Jun 2020
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Platform Technology Partners holds $20,918,051 across 11 Drug Manufacturers - General names. GILD ranks #10 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
24,647 | $6,259,598 | |
| 2 | LLY |
ELI LILLY & Co
|
3,230 | $3,874,159 | |
| 3 | AMGN |
Amgen Inc
|
8,500 | $3,078,020 | |
| 4 | ABBV |
AbbVie Inc.
|
10,636 | $2,676,443 | |
| 5 | MRK |
Merck & Co., Inc.
|
13,444 | $1,727,554 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
20,385 | $1,174,583 | |
| 7 | PFE |
Pfizer Inc
|
22,870 | $550,709 | |
| 8 | NVO |
Novo Nordisk A S
|
10,941 | $524,511 |
All Filings in GILD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $343,139 | 2,716 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $456,994 | 3,279 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $329,802 | 2,687 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $292,374 | 2,634 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $612,667 | 5,526 | Shares | Sole | 2025-08-11 | |
| 2021-06-30 | $229,510 | 3,333 | Shares | Sole | 2021-08-05 | |
| 2020-09-30 | $311,969 | 4,937 | Shares | Sole | 2020-11-30 | |
| 2020-06-30 | $283,908 | 3,690 | Shares | Sole | 2020-11-30 | |
| No filing history on record for this holder in this stock. | ||||||